GlassScriptPhysician profile
Michelle Pedersen
NPI 1700260601
$649.28
in general payments reported to CMS, 2019-2025
12 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $120 · 2021: $93.75 · 2024: $93.10 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $124.80 | 2019 | |
| Pfizer INC. | $120.20 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.75 | 2021 | |
| Daiichi Sankyo INC. | $73.03 | 2025 | Vanflyta |
| Janssen Biotech, INC. | $57.74 | 2025 | Erleada |
| Exelixis INC. | $36.20 | 2024-2025 | Cabometyx |
| Amgen INC. | $29.78 | 2019 | |
| Tempus Ai, INC | $26.66 | 2024 | |
| Alnylam Pharmaceuticals INC. | $26.23 | 2024 | Givlaari |
| Eisai INC. | $22.29 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.84 | 2024 | |
| Merck Sharp & Dohme LLC | $17.76 | 2025 | Keytruda, Welireg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Pedersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.